CD8A and non-small cell lung carcinoma: Sulforaphane Synergizes With PD-1 Blockade Through Activating CD8&lt;sup&gt;+&lt;/sup&gt; T Cells in Non-Small Cell Lung Cancer: Preclinical and Clinical Investigations.